Interferon alpha in the establishment of latency by herpes simplex virus type 1 strain tr.

• Autorzy: Wieczorek M , Litwinska B.
• Języki publikacji: EN

Abstrakty

EN

The effect of interferon (IFN) alpha on the establishment and maintenance of neuronal latency and viral reactivation is still not known. Using cell culture methods and sensitive RT-PCR methods, we show that the presence of antiserum to IFN alpha promotes the establishment of HSV-1 tr latent infection. We suggest that IFN alpha is an important tool not only for the control of productive but also latent HSV-1 infection.

Słowa kluczowe

EN

interferon alpha; latent infection; herpes simplex virus type 1; herpesvirus; microbiology

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2006
• Tom: 55
• Numer: 1
• Opis fizyczny: p.49-52,fig.,ref.

Twórcy

autor

Wieczorek M

• National Institute of Hygiene, Warsaw, Poland

autor

Litwinska B.

Bibliografia

• Chatterjee S., A.D. Lakeman, R.J. Whitley and E. Hunter. 1984. Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virus. Virus Research 1: 81-87.
• Devi-Rao G.B., D.C. Bloom, J.G. Stevens and E.K. Wagner. 1994. Herpes simplex virus type 1 DNA replication and gene expresión during explant-induced reactivation of latently infectedd murine sensory ganglia. J. Virol. 68: 1271-1282.
• Domke-Opitz I., P. Straub and H. Kirchner. 1986. Effect of interferon on replication of herpes simplex virus types 1 and 2 in human macrophages. J. Virol. 60: 37-42.
• Fraser N.W., T.M. Block and J.G. Spivack. 1992. The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology 191: 1-8.
• Halford W.P., B.M. Gebhardt and D.J.J. Carr. 1996. Peristent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157: 3542-3549.
• Harle P., E. Lauret, P.M. Pitha, E. De Maeyer and D.J. Carr. 2001. Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-beta is more potent than IFN alpha2. Virology 290: 237-248.
• Halford W.P. and P.A. Schaffer. 2000. Optimized viral dose and transient immunosuppression enable herpes simplex virus ICPO-null mutants to establish wild type levels of latency in vivo. J. Virol. 74: 5957-5967.
• Hendricks R.L., P.C. Weber, J.L. Taylor, A. Koumbis, T.M. Turnpey and J.C. Glorioso. 1991. Endogenously produced interferon alpha prootects mice from herpes simplex virus type 1 corneal disease. J. General Virol. 72: 1601-1610.
• Kramer M.F. and D.M. Coen. 1995. Quantification of transcripts from the ICP4 and thymidine kinase genes in mose ganglia latently infected with herpes simplex virus. J. Virol. 69: 1389-1399.
• Kramer M.F., S.H. Chen, D.M. Knipe and D.M. Coen. 1998. Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J. Virol. 72: 1177-1185.
• Litwińska B., W. Sadowski and M. Kańtoch. 1991. Temperature-sensitive clones of herpes simplex virus type 1 from laboratory and clinical strains. I. Cloning and basic pathogenetic and immunogenic properties (in Polish). Med. Dośw. Mikrobiol. 43: 55-62.
• Lausch R.N., Y.H. Su, M. Ritchie and J.E. Oakes. 1991. Evidence endogenous interferon production contributed to the lack of ocular virulence of an HSV intertypic recombinant. Current Eye Research 10: 39-45.
• Noisakran S., I.L. Campbell and D.J. Carr. 1999. Ectopic expression of DNA encoding IFN-alphal in the cornea protects mice from herpes simplex virus type-1-induced encephalitis. J. Immunol. 162: 4184-4190.
• Oberman F. and A. Panet. 1988. Inhibition of transcription of herpes simplex virus immediate early genes in interferon treated human cells. J. General Virol. 69: 1167-1177.
• Pinto A.J., P.S. Morahan, M. Brinton, D. Stewart and E. Gavin. 1990. Comparative therapeutic efficacy of recombinant interferon-alpha, -beta, and-gamma against alphatogavirus, bunyavirus, flavivirus and herpesvirus infections. J. Interferon Research 10: 293-298.
• Ramakrishnan R., M. Levine and D.J. Fink. 1994. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J. Virol. 68: 7083-7091.
• Sawtell N.M. 1997. Comprehensive quantification of herpes simplex virus latency at the single cell level. J. Virol. 71: 5423-5431.
• Sawtell N.M. 1998. The probability of in vivo reactivation of herpes simplex virus type 1 increases with number of latently infected neurons in ganglia. J. Virol. 72: 6888-6892.
• Stevens J.G., E.K. Wagner, G.B. Devi-Rao, M.L. Cook and L.T. Feldman. 1987. RNA complementary to a herpes virus gene mRNA is prominent in latently infected neurons. Science 235: 1056-1059.
• Su Y-H, R.L. Meegalla, R. Chowhan, C. Cubitt, J.E. Oakes, R.N. Lausch, N.W. Fraser and T. Block. 1999. Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells. J. Virol. 73: 4171-4180.
• Su Y.-H., J.E. Oakes and R.N. Lausch. 1990. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon. J. Virol. 64: 2187-2192.
• Tal-Singer R., T.M. Lasner, W. Podrzucki, A. Skokotas, J.J. Leary, S.L. Berger and N.W. Fraser. 1997. Gene expresión during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J. Virol. 71: 5268-5276.
• Wagner E.K. and D.C. Bloom. 1997. Experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 10: 419-443.